Edition:
United States

Trovagene Inc (TROV.OQ)

TROV.OQ on NASDAQ Stock Exchange Capital Market

2.55USD
2:46pm EST
Change (% chg)

$-0.15 (-5.56%)
Prev Close
$2.70
Open
$2.70
Day's High
$2.75
Day's Low
$2.50
Volume
28,071
Avg. Vol
42,644
52-wk High
$6.92
52-wk Low
$2.50

TROV.OQ

Chart for TROV.OQ

About

Trovagene, Inc. (TrovaGene) is a molecular diagnostic company. The Company focuses on the development and commercialization of a molecular diagnostic technology for use in disease detection and monitoring across a range of medical disciplines. Its primary internal focus is to leverage its cell-free molecular diagnostic platform... (more)

Overall

Beta: 0.97
Market Cap(Mil.): $91.85
Shares Outstanding(Mil.): 30.62
Dividend: --
Yield (%): --

Financials

  TROV.OQ Industry Sector
P/E (TTM): -- 32.25 29.87
EPS (TTM): -1.27 -- --
ROI: -65.30 13.46 14.95
ROE: -93.25 17.16 16.29

BRIEF-Trovagene selected as liquid biopsy provider

* Selected as liquid biopsy provider to participate in first large-scale precision medicine trial for patients with pancreatic cancer

Oct 04 2016

BRIEF-Trovagene reports Q2 loss per share $0.34

* Trovagene reports second quarter 2016 financial results and accomplishments

Aug 04 2016

BRIEF-Trovagene entered into Fifth amendment to loan and security agreement with Oxford Finance, Silicon Valley Bank

* On July 20, 2016, Co entered into Fifth amendment to loan and security agreement with Oxford Finance LLC, Silicon Valley Bank

Jul 26 2016

Earnings vs. Estimates